open access

Vol 10, No 5 (2015)
Review Papers
Published online: 2015-10-28
Get Citation

Perioperative procedures in patients with implanted drug-eluting stents

Paweł Rajwa, Grzegorz Rempega, Kamil Suliga, Bożena Szyguła-Jurkiewicz
DOI: 10.5603/FC.2015.0064
·
Folia Cardiologica 2015;10(5):336-341.

open access

Vol 10, No 5 (2015)
Review Papers
Published online: 2015-10-28

Abstract

Considering the fact that the majority of stents implanted during percutaneous coronary intervention are drug-eluting stents (DES) and 5–25% of patients require a non-cardiac surgery within 5 years of implanting the stent, appropriate therapeutic procedures in the perioperative period are clinically significant. To prevent late thrombosis in patients with implanted DES, it is recommended to prolong — compared to implantation of bare metal stents — dual antiplatelet therapy. In the perioperative period, it is crucial to maintain balance between the risk of a potentially fatal haemorrhage and stent thrombosis. Taking into account the fact that premature cessation of dual antiplatelet therapy is the most significant risk factor of stent thrombosis, correct perioperative actions in patients with high risk of bleeding may present many clinical difficulties. In the study, factors that impact the risk of thrombosis and haemorrhage, as well as up-to-date guidelines and methods regarding the perioperative period procedures in patients with implanted DES have been presented.

Abstract

Considering the fact that the majority of stents implanted during percutaneous coronary intervention are drug-eluting stents (DES) and 5–25% of patients require a non-cardiac surgery within 5 years of implanting the stent, appropriate therapeutic procedures in the perioperative period are clinically significant. To prevent late thrombosis in patients with implanted DES, it is recommended to prolong — compared to implantation of bare metal stents — dual antiplatelet therapy. In the perioperative period, it is crucial to maintain balance between the risk of a potentially fatal haemorrhage and stent thrombosis. Taking into account the fact that premature cessation of dual antiplatelet therapy is the most significant risk factor of stent thrombosis, correct perioperative actions in patients with high risk of bleeding may present many clinical difficulties. In the study, factors that impact the risk of thrombosis and haemorrhage, as well as up-to-date guidelines and methods regarding the perioperative period procedures in patients with implanted DES have been presented.

Get Citation

Keywords

drug-eluting stents, perioperative procedures, antiplatelet agents

About this article
Title

Perioperative procedures in patients with implanted drug-eluting stents

Journal

Folia Cardiologica

Issue

Vol 10, No 5 (2015)

Pages

336-341

Published online

2015-10-28

DOI

10.5603/FC.2015.0064

Bibliographic record

Folia Cardiologica 2015;10(5):336-341.

Keywords

drug-eluting stents
perioperative procedures
antiplatelet agents

Authors

Paweł Rajwa
Grzegorz Rempega
Kamil Suliga
Bożena Szyguła-Jurkiewicz

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl